Crinetics Pharmaceuticals, Inc. (CRNX)
USD 52.09
(-5.92%)
USD 52.09
(-5.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.01 Million | 4.73 Million | 1.07 Million | 71 Thousand | 1.19 Million | 2.42 Million |
| Cost of Revenue | - | 1.38 Million | 1.26 Million | 56.99 Million | 1.11 Million | 24.47 Million |
| Gross Profit | 4.01 Million | 3.34 Million | -184 Thousand | -56.92 Million | 80 Thousand | -22.05 Million |
| Operating Expenses | 226.62 Million | 172.61 Million | 108.78 Million | 74.95 Million | 53.83 Million | 28.71 Million |
| Selling, General and Administrative Expenses | 58.09 Million | 42.39 Million | 24.52 Million | 18.02 Million | 13.51 Million | 6.65 Million |
| Research and Development Expenses | 168.52 Million | 130.22 Million | 84.25 Million | 56.99 Million | 41.5 Million | 24.47 Million |
| Other Expenses | - | 4.97 Million | 61 Thousand | -71 Thousand | -1.19 Million | 1.59 Million |
| Cost and Expenses | 226.62 Million | 172.61 Million | 108.78 Million | 74.95 Million | 53.83 Million | 28.71 Million |
| Operating Income | -222.6 Million | -167.88 Million | -107.7 Million | -74.95 Million | -53.83 Million | -28.71 Million |
| Interest Expense | - | 4.31 Million | - | - | - | - |
| Income Tax Expense | - | -3.96 Million | -922 Thousand | -948 Thousand | -887 Thousand | 1.59 Million |
| Earnings before Tax | -214.52 Million | -163.91 Million | -107.64 Million | -73.81 Million | -50.42 Million | -27.11 Million |
| Net Income | -214.52 Million | -159.95 Million | -106.71 Million | -72.86 Million | -49.53 Million | -27.11 Million |
| Earnings Per Share Basic | -3.69 | -3.08 | -2.78 | -2.39 | -2.05 | -2.23 |
| Earnings Per Share Diluted | -3.69 | -3.08 | -2.78 | -2.39 | -2.05 | -2.23 |
| Weighted Average Shares Outstanding | 58.07 Million | 51.98 Million | 38.43 Million | 30.44 Million | 24.17 Million | 12.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.07 Million | 51.98 Million | 38.43 Million | 30.44 Million | 24.17 Million | 12.14 Million |
| Gross Margin | 1.00 | 0.71 | -0.17 | -801.79 | 0.07 | -9.08 |
| EBIT Margin | -55.20 | -35.44 | -99.91 | -1055.68 | -45.12 | -11.82 |
| Profit Margin | -53.46 | -33.77 | -99.00 | -1026.25 | -41.52 | -11.17 |
| EBITDA | -221.51 Million | -166.89 Million | -106.78 Million | -72.58 Million | -49.3 Million | -28.23 Million |
| Earnings Before Tax Margin | -55.47 | -35.44 | -99.91 | -1055.68 | -45.12 | -11.82 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 399 Thousand | 640 Thousand | - | 4.01 Million | 346 Thousand | 988 Thousand |
| Cost of Revenue | 753 Thousand | 474 Thousand | 262 Thousand | 1.09 Million | 273 Thousand | 398 Thousand |
| Gross Profit | -354 Thousand | 166 Thousand | -262 Thousand | 2.91 Million | 73 Thousand | 590 Thousand |
| Operating Expenses | 82.42 Million | 73.69 Million | 62.39 Million | 225.52 Million | 59.32 Million | 53.98 Million |
| Selling, General and Administrative Expenses | 24.83 Million | 20.82 Million | 17.07 Million | - | 15.48 Million | 13.34 Million |
| Research and Development Expenses | 57.59 Million | 52.86 Million | 45.31 Million | - | 43.83 Million | 40.64 Million |
| Other Expenses | -13 Thousand | -251 Thousand | 40 Thousand | -159 Thousand | 2.51 Million | -91 Thousand |
| Cost and Expenses | 83.18 Million | 74.16 Million | 62.65 Million | 226.62 Million | 59.32 Million | 53.98 Million |
| Operating Income | -83.18 Million | -74.16 Million | -62.65 Million | -222.6 Million | -58.97 Million | -52.99 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -1.00 | 218.18 Thousand | 930.1 Thousand | -273 Thousand | -2.1 Million |
| Earnings before Tax | -74.05 Million | -66.93 Million | -60.09 Million | -214.52 Million | -57.45 Million | -50.97 Million |
| Net Income | -74.05 Million | -66.93 Million | -60.09 Million | -214.52 Million | -57.45 Million | -50.97 Million |
| Earnings Per Share Basic | -0.94 | -0.93 | -0.90 | - | -1.01 | -0.94 |
| Earnings Per Share Diluted | -0.94 | -0.93 | -0.90 | - | -1.01 | -0.94 |
| Weighted Average Shares Outstanding | 79 Million | 72.28 Million | 67.14 Million | 58.07 Million | 56.8 Million | 54.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 79 Million | 72.28 Million | 67.14 Million | 58.07 Million | 56.8 Million | 54.27 Million |
| Gross Margin | -0.89 | 0.26 | - | 0.73 | 0.21 | 0.60 |
| EBIT Margin | -206.59 | -115.15 | - | - | -170.45 | -53.36 |
| Profit Margin | -185.60 | -104.58 | - | -53.46 | -166.06 | -51.60 |
| EBITDA | -82.42 Million | -73.69 Million | -62.39 Million | - | -58.97 Million | -52.71 Million |
| Earnings Before Tax Margin | -208.48 | -115.89 | - | -55.47 | -170.45 | -53.64 |
CHOLAHLDNG
BASANTGL
ACR-PC
UPST
WANBURY
0QQ4